Search Legislation

The Medicines (Advertising Amendments) Regulations 2005

 Help about what version

What Version

 Help about opening options

Opening Options

Status:

This is the original version (as it was originally made).

Amendment of regulation 2 of the principal Regulations

This section has no associated Explanatory Memorandum

2.  In regulation 2 of the principal Regulations (interpretation)—

(a)in the appropriate alphabetical place, insert the following definitions—

“certificate of registration” means a certificate of registration granted by the licensing authority under the Medicines (Homoeopathic Medicinal Products for Human Use) Regulations 1994(1);

“homoeopathic medicinal product” means a medicinal product (which may contain a number of principles) prepared from substances called homoeopathic stocks in accordance with a homoeopathic manufacturing procedure described by the European Pharmacopoeia or, in the absence thereof, any pharmacopoeia used officially in a Member State; and

“traditional herbal registration” means a registration granted by the licensing authority under the Medicines (Traditional Herbal Medicinal Products for Human Use) Regulations 2005(2);;

(b)in the definition of “the 2001 Directive”, after “as amended” insert—

  • by—

    (a)

    Directive 2002/98/EC of the European Parliament and of the Council setting standards of quality and safety for the collection, testing, processing, storage and distribution of human blood and blood components(3),

    (b)

    Commission Directive 2003/63/EC amending Directive 2001/83/EC on the Community code relating to medicinal products for human use(4),

    (c)

    Directive 2004/24/EC of the European Parliament and of the Council amending, as regards traditional herbal medicinal products, Directive 2001/83/EC on the Community code relating to medicinal products for human use(5), and

    (d)

    Directive 2004/27/EC of the European Parliament and of the Council amending Directive 2001/83/EC on the Community code relating to medicinal products for human use(6);

(c)for the definition of “marketing authorization” substitute—

“marketing authorization” means—

(a)

a marketing authorization granted by the licensing authority under the Medicines for Human Use (Marketing Authorisations Etc.) Regulations 1994(7),

(b)

a marketing authorization granted by the European Commission under Council Regulation (EEC) 2309/93(8) or under Regulation (EC) No. 726/2004 of the European Parliament and of the Council laying down Community procedures for the authorisation and supervision of medicinal products for human and veterinary use and establishing a European Medicines Agency(9),

(c)

an authorization granted by the licensing authority in accordance with Article 126a of the 2001 Directive, or

(d)

a product licence granted by the licensing authority under Part II of the Act;;

(d)in the definition of “relevant medicinal product”—

(i)for paragraph (a) substitute—

(a)a medicinal product for human use to which the 2001 Directive applies and accordingly includes products to which Title II of Regulation (EC) No. 726/2004 applies, or,

(ii)in paragraph (b), in sub-paragraph (ii), omit “or”, and

(iii)omit paragraph (c); and

(e)in the definition of “summary of product characteristics”, for “product licence” substitute “marketing authorization or traditional herbal registration”.

(1)

S.I. 1994/105; as amended by S.I. 1994/899, 1995/541, 1996/482, 1998/574, 1999/566, 2001/795, 2002/236 and 542, 2003/625 and 2321, and 2004/666.

(2)

S.I. 2005/2750.

(3)

OJ No. L33, 8.2.2003, p.30.

(4)

OJ No. L159, 27.6.2003, p.46.

(5)

OJ No. L136, 30.4.2004, p.85.

(6)

OJ No. L136, 30.4.2004, p.34.

(7)

S.I. 1994/3144; relevant amending instruments S.I. 1998/3105, 2000/292, 2001/795, 2002/236, 2002/542, 2003/2321, 2004/3224 and 2005/2759.

(8)

OJ No. L214, 24.8.1993, p.1.

(9)

OJ No. L136, 30.4.2004, p.1.

Back to top

Options/Help

Print Options

Close

Legislation is available in different versions:

Latest Available (revised):The latest available updated version of the legislation incorporating changes made by subsequent legislation and applied by our editorial team. Changes we have not yet applied to the text, can be found in the ‘Changes to Legislation’ area.

Original (As Enacted or Made): The original version of the legislation as it stood when it was enacted or made. No changes have been applied to the text.

Close

Opening Options

Different options to open legislation in order to view more content on screen at once

Close

Explanatory Memorandum

Explanatory Memorandum sets out a brief statement of the purpose of a Statutory Instrument and provides information about its policy objective and policy implications. They aim to make the Statutory Instrument accessible to readers who are not legally qualified and accompany any Statutory Instrument or Draft Statutory Instrument laid before Parliament from June 2004 onwards.

Close

More Resources

Access essential accompanying documents and information for this legislation item from this tab. Dependent on the legislation item being viewed this may include:

  • the original print PDF of the as enacted version that was used for the print copy
  • lists of changes made by and/or affecting this legislation item
  • confers power and blanket amendment details
  • all formats of all associated documents
  • correction slips
  • links to related legislation and further information resources
Close

More Resources

Use this menu to access essential accompanying documents and information for this legislation item. Dependent on the legislation item being viewed this may include:

  • the original print PDF of the as made version that was used for the print copy
  • correction slips

Click 'View More' or select 'More Resources' tab for additional information including:

  • lists of changes made by and/or affecting this legislation item
  • confers power and blanket amendment details
  • all formats of all associated documents
  • links to related legislation and further information resources